Table 4.
Mean EQ-5D scores and visual analogue health scale scores for groups at baseline, three months, and six months follow up
|
Intervention group (n=429)
|
Control group (n=426)
|
Difference*in change over six months, with 95% CI and P value† | |||
|---|---|---|---|---|---|
| Measure | Score (SD) | No of respondents | Score (SD) | No of respondents | |
| EQ-5D | |||||
| Baseline | 0.59 (0.29) | 422 | 0.63 (0.28) | 417 | |
| Three months | 0.47 (0.32) | 320 | 0.48 (0.32) | 325 | |
| Six months | 0.46 (0.33) | 311 | 0.50 (0.31) | 288 | |
| Change over six months | −0.131 (0.33) | 308 | −0.137 (0.34) | 284 | 0.006 (−0.048 to 0.059; P=0.84) |
| Visual analogue health scale | |||||
| Baseline | 62.2 (18.3) | 404 | 62.3 (18.5) | 406 | |
| Three months | 54.3 (19.5) | 322 | 55.6 (20.1) | 315 | |
| Six months | 54.9 (19.8) | 303 | 58.8 (19.4) | 275 | |
| Change over six months | −7.36 (24.4) | 284 | −3.24 (23.0) | 266 | −4.12 (−8.09 to −0.15; P=0.042) |
*
Intervention minus control.
†
t test.